BHI News Section Archives - Page 48 of 1201

News

April 30, 2024

QIAGEN reports results for Q1 2024 ahead of outlook, on track to achieve full-year 2024 guidance

Venlo, the Netherlands, April 29, 2024 (GLOBE NEWSWIRE) -- QIAGEN N.V. (NYSE: QGEN; Frankfurt Prime Standard: QIA) today announced results…

Andy

Love0

News

April 29, 2024

MedCityNews: An Oveview of the Nation’s Largest SEED Fund

Eligible small businesses may receive millions of non-dilutive dollars from NIH’s Small Business Innovative Research (SBIR) and Small Business Technology…

Andy

Love0

News

April 29, 2024

Deloitte Acquires Gryphon Scientific Business to Expand Security, Science and Public Health Capabilities

Acquisition will strengthen Deloitte team with a complement of data-driven biosecurity detection, prevention and emergency response solutions ARLINGTON, Va., April 29,…

Andy

Love0

News

April 29, 2024

Pitchbook: The World’s Top Startup Cities

PitchBook’s VC Ecosystem Rankings compare global cities based on the size and maturity of their startup networks. The framework helps…

Andy

Love0

News

April 28, 2024

Venable Ranks Among American Lawyer Magazine’s Top 100 Firms

Washington, DC (April 17, 2024) – Venable LLP is pleased to announce that it has been named to American Lawyer magazine’s 2024 Am Law 100…

Andy

Love0

News

April 28, 2024

AURP Wins Stage One of the U.S. Small Business Administration’s 2024 Growth Accelerator Fund Competition

AURP awarded $50,000 in prize money for equitable access to entrepreneurship WASHINGTON, DC, and TUCSON, AZ / ACCESSWIRE / April…

Andy

Love0

News

April 26, 2024

Virginia Innovation Partnership Corporation (VIPC) Names Joe Benevento as President & CEO

Benevento to lead Virginia’s strategic authority that invests in startup companies, entrepreneurship ecosystems, university commercialization, innovation growth VIPC is well-positioned…

Andy

Love0

News

April 25, 2024

Gain Therapeutics Announces Positive Results from the Single Ascending Dose (SAD) Part of the Phase 1 Clinical Trial of GT-02287, a Novel GCase-Targeting Small Molecule Therapy for GBA1 Parkinson’s Disease

BETHESDA, Md., April 24, 2024 (GLOBE NEWSWIRE) -- Gain Therapeutics, Inc. (Nasdaq: GANX) (“Gain”, or the “Company”), a clinical-stage biotechnology…

Andy

Love0

News

April 25, 2024

United Therapeutics Announces World’s First Successful Xenothymokidney Transplant

The first living recipient of a UThymoKidney, in conjunction with a heart pump implant, is recovering after a successful transplant…

Andy

Love0

News

April 24, 2024

BISNOW: ‘Signs Of Rebound’ Emerging In Biotech, $11B In VC Funds To Kick-Start Recovery, Alexandria Says

April 23, 2024, Patrick Sisson, Bisnow National - One of the life sciences real estate’s biggest players sees a clear…

Andy

Love0

BHI News Section

QIAGEN reports results for Q1 2024 ahead of outlook, on track to achieve full-year 2024 guidance

MedCityNews: An Oveview of the Nation’s Largest SEED Fund

Deloitte Acquires Gryphon Scientific Business to Expand Security, Science and Public Health Capabilities

Pitchbook: The World’s Top Startup Cities

Venable Ranks Among American Lawyer Magazine’s Top 100 Firms

AURP Wins Stage One of the U.S. Small Business Administration’s 2024 Growth Accelerator Fund Competition

Virginia Innovation Partnership Corporation (VIPC) Names Joe Benevento as President & CEO

Gain Therapeutics Announces Positive Results from the Single Ascending Dose (SAD) Part of the Phase 1 Clinical Trial of GT-02287, a Novel GCase-Targeting Small Molecule Therapy for GBA1 Parkinson’s Disease

United Therapeutics Announces World’s First Successful Xenothymokidney Transplant

BISNOW: ‘Signs Of Rebound’ Emerging In Biotech, $11B In VC Funds To Kick-Start Recovery, Alexandria Says

About BioHealth Innovation

Contact

Connect

BHI News Section

About BioHealth Innovation

Contact

Connect

Search